{"database":"ENA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Massachusetts General Hospital, Harvard Medical School"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA1014445"],"scientific_name":["Homo sapiens"],"long_description":["High-grade serous ovarian cancer (HGSC) is a challenging disease, especially for patients with immunologically 'cold' tumors devoid of tumor-infiltrating lymphocytes (TIL). HGSC exhibits among the highest levels of MYCN transcriptional signature in human cancer, which is strongly linked to diminished features of anti-tumor immunity. We used microarrays to identify genes potentially dysregulated by the oncogene N-MYC in HGSC cell lines. Overall design: CaOV3 TET-On MYCN-GFP and GFP control cells were cultured in the presence or absence of 1 ug/ml of Doxycycline (DOX) and collected for RNA extraction and hybridization on Clariom S microarrays."],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"Expression data from CaOV3 TET-On cell line with MYCN inducible expression.","description":"Expression data from CaOV3 TET-On cell line with MYCN inducible expression.","dates":{"last_updated":"2025-09-24","first_public":"2023-12-09"},"accession":"PRJNA1014445","cross_references":{"GEO":["GSE242747"],"taxon":["9606"]}}